Clinical Trials Browser

Carcinoma, Hepatocellular × Radiation × Clear all

NCT03942328 2026-02-24

Modified Immune Cells (Autologous Dendritic Cells) and a Vaccine (Prevnar) Combined With Immune Checkpoint Inhibition After High-Dose External Beam Radiation Therapy in Treating Patients With Unresectable Liver Cancer

Phase 1/2 Recruiting

Gastrointestinal

Carcinoma, Hepatocellular, Cholangiocarcinoma

NCT03186898 2026-02-13

Radiation Therapy With Protons or Photons in Treating Patients With Liver Cancer

Phase 3 Active not recruiting

Gastrointestinal

Carcinoma, Hepatocellular

NCT02626312 2025-10-14

Radiation Therapy in Treating Patients With Hepatocellular Carcinoma, Cholangiocarcinoma, or Liver Metastasis Who Have Impaired Liver Function

Phase 1 Active not recruiting

Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular, Cholangiocarcinoma

NCT07027436 2025-06-18

DARTS

Phase 3 Not yet recruiting

Gastrointestinal

Carcinoma, Hepatocellular

NCT03482102 2022-09-08

Durvalumab (MEDI4736) and Tremelimumab and Radiation Therapy in Hepatocellular Carcinoma and Biliary Tract Cancer

Phase 2 Recruiting

Gastrointestinal

Biliary Tract Neoplasms, Carcinoma, Hepatocellular

NCT04722120 2022-02-14

Low Contrast Agent and Radiation Dose Protocol for Liver CT in Patients With HCC

Phase NA Completed

Gastrointestinal

Carcinoma, Hepatocellular